Business Wire

Leapmotor unveils its entire new product line at the Shanghai International Auto Show

Share

On April 18th, the 20th Shanghai International Auto Show officially kicked off, and Leapmotor (Zhejiang Leapmotor Technology Co Ltd, HKG: 9863) brought its entire new product line to the event, including the C11 extended range model, the 2023 C01, C11, and T03. Leapmotor Chairman Zhu Jiangming, along with other executives, transformed into "super test drivers" and personally drove the cars to give users a close-up experience of the company's commitment to being an "OEM for the users."

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230418006053/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

Leapmotor's entire new product line with their value propositions, making car selection and purchase less of a hassle.

The C11 extended range model boasts a 285km pure electric range leading in its class, with a maximum comprehensive range of 1024km, a 2930mm extra-long wheelbase, and features such as an immersive triple-screen display, Nappa leather seats, frameless doors, and a premium quality music cockpit, all of which elevate the luxurious experience. In addition, the C11 extended range model is equipped with 28 perception hardware devices, with as many as 23 driving assistance functions launched at once, allowing users to calmly handle complex driving scenarios such as city and high-speed driving over long distance.

The 2023 C01 model is equipped with the CTC battery-chassis integration technology, with a maximum comprehensive range of 717km under CLTC. The C01 has a maximum power of 400kW and a maximum torque of 720N·m, with hidden door handles, a sleek body, and dynamic tail lights that create a super-low drag coefficient that leads its class. It achieves acceleration from 0 to 100km/h in just over 3 seconds, providing users with an ultimate driving experience.

The 2023 C11 model's intelligent cockpit is equipped with a Qualcomm Snapdragon SA8155P chip, an immersive triple-screen display, and a highly integrated full-touch-control design that provides a smooth experience and supports AI face recognition and other functions. The C11 uses variable architecture high-performance oil-cooled electric drive, with a 0 to 100km/h acceleration time in just 3.94 seconds. The double-wishbone front and 5-link rear independent suspensions comparable to luxury cars greatly improve the handling quality and driving experience of the entire vehicle, while also balancing comfort and handling performance.

The 2023 Leapmotor T03 is positioned as an ultra-safe 5-door electric vehicle, with a 5-door 4-seat, 2400mm long wheelbase design, and a cage-like body with a high-strength steel ratio of up to 68%. It also has up to 10 automatic driving assistance functions, providing double protection for safe driving. In addition, the T03 has passed the EU’s Small Whole Vehicle Type Approval (SWVTA), and Leapmotor will continue to expand its overseas market, further accelerating its global strategic layout.

Chairman serves as “Super Test Driver” and personally drives the guests

The booth layout was inspired by hand-drawn sketches from Leapmotor's founder chairman Zhu Jiangming. In addition to providing free coffee, lunch, fruit, and other services, Zhu Jiangming also held a lunch meeting with the media and users to exchange insights on Leapmotor's car-making, product planning, user needs, and driving experiences in a relaxed chat.

Moreover, Leapmotor also held the “Super Test Driver” event at this year’s auto show, where Zhu and other executives personally drove and chauffeured users, making it more convenient for their attendance.

Leapmotor, beyond your expectation.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tammy Hu
Email: Gmail:Leapmotorglobal@gmail.com
+86 15068893526

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit28.4.2024 14:57:00 EEST | Press release

TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/ TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire) Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye